Mereo BioPharma Group Plc (MREO)
2.18
+0.05
(+2.35%)
USD |
NASDAQ |
Dec 09, 16:00
2.19
+0.01
(+0.46%)
After-Hours: 20:00
Mereo BioPharma Group EPS Diluted (Quarterly): -0.0436 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Adaptimmune Therapeutics Plc | -0.1163 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1348 |
| Autolus Therapeutics Plc | -0.2955 |
| Bicycle Therapeutics Plc | -0.8476 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.982M |
| Total Expenses (Quarterly) | 6.982M |
| Enterprise Value | 298.32M |
| Earnings Yield | -12.09% |
| Normalized Earnings Yield | -12.22 |